Xiayang Qiu is the founder of Regor Therapeutics. Regor Therapeutics has raised $90M in total funding. Latest round: Series B. Based in Shanghai, China.
Xiayang Qiu is a co-founder of Regor Therapeutics, a clinical-stage biotechnology company founded in July 2018. He is an elite drug researcher and developer, credited with helping identify Regor's lead compound for metabolic disorders, RGT-075, using the company's CARD platform. Qiu was involved in the company's early development and its $90 million Series B financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library